Plain-English translation of NCT07125352 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at a simple blood test measurement called the neutrophil-to-lymphocyte ratio—essentially counting two types of white blood cells and comparing them—in patients experiencing a sudden flare-up of chronic obstructive pulmonary disease (COPD). Researchers believe this ratio might help doctors quickly predict how serious the flare-up is and what the patient's recovery might look like. The goal is to find a fast, inexpensive way to measure disease severity during these dangerous episodes.
COPD flare-ups are a major cause of death worldwide and can happen suddenly, making it hard for doctors to quickly predict how ill someone will become. This measurement already shows promise in other serious illnesses, so researchers want to see if the same approach can help guide treatment decisions in COPD patients more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood samples taken as part of your normal hospital care for your COPD flare-up. Researchers will measure the ratio of white blood cells in your blood and track how you recover, but you won't need to do anything extra beyond what's already planned for your hospital stay. The study simply uses information from routine blood tests and your medical records to see if this measurement can predict how severe your condition is.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt